Suchergebnisse - "Egleston, Brian L"

PubPharm (7)

1

The critical need to implement and utilize patient-reported measures of function in cancer care delivery

enthalten in: Cancer | 2022

von Fu, J. | Stout, N. | Egleston, B.

CommentOn: Cancer. 2022 Sep 1;128(17):3217-3223. - PMID 35788990

2

For Health-Related Quality of Life and Other Longitudinal Data, Analysis Should Distinguish Between Truncation by Death and Data Missing Because of Nonresponse

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2016

von Kurland, B. | Egleston, B.

CommentOn: J Clin Oncol. 2016 Jun 1;34(16):1953-6. - PMID 27091712

3

Reply to P. Blanchard et al

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2016

von Murphy, C. | Galloway, T. | Handorf, E. | +2

CommentOn: J Clin Oncol. 2016 Jan 10;34(2):169-78. - PMID 26628469

4

Atomic bomb survivor cataract surgery prevalence data are consistent with non-zero threshold dose--Comment on article by Nakashima et al. 2013

enthalten in: Health physics | 2014

von Doss, M. | Egleston, B. | Litwin, S.

CommentOn: Health Phys. 2013;105(3):253–60

5

Comments on "Studies of the mortality of atomic bomb survivors, report 14, 1950-2003 : an overview of cancer and noncancer diseases" (Radiat Res 2012; 177:229-43)

enthalten in: Radiation research | 2012

von Doss, M. | Egleston, B. | Litwin, S.

CommentOn: Radiat Res. 2012 Mar;177(3):229-43. - PMID 22171960

6

Should partial nephrectomy be offered to all patients whenever technically feasible?

enthalten in: European urology | 2012

von Kutikov, A. | Smaldone, M. | Egleston, B. | +1

CommentOn: Eur Urol. 2012 Apr;61(4):725-31. - PMID 22172373

7

Response to Pearl's comments on principal stratification

enthalten in: The international journal of biostatistics | 2011

von Egleston, B.

CommentOn: Int J Biostat. 2011;7(1):20. - PMID 21556288

1
[1]